Kroeger Christopher A. has filed 29 insider transactions across 1 company since October 2025.
Most recent transaction: a sale of 118037 shares of MapLight Therapeutics, Inc. ($MPLT) on May 18, 2026.
Activity breakdown: 0 open-market purchases and 22 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 118037 | $27.19 | 1,394,292.0000 | 45,373,033 | 7.80% | 0.26% |
| May 18, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 198 | $28.15 | 1,394,094.0000 | 45,373,033 | 0.01% | 0.00% |
| May 11, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 6871 | $30.04 | 1,619,409.0000 | 45,373,033 | 0.42% | 0.02% |
| May 7, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 5220 | $29.15 | 1,661,910.0000 | 45,373,033 | 0.31% | 0.01% |
| May 11, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 877 | $28.70 | 1,626,280.0000 | 45,373,033 | 0.05% | 0.00% |
| May 11, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 342 | $27.57 | 1,627,157.0000 | 45,373,033 | 0.02% | 0.00% |
| May 8, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 3205 | $29.20 | 1,627,499.0000 | 45,373,033 | 0.20% | 0.01% |
| May 7, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 14880 | $28.47 | 1,667,130.0000 | 45,373,033 | 0.88% | 0.03% |
| May 8, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 1582 | $28.56 | 1,630,704.0000 | 45,373,033 | 0.10% | 0.00% |
| May 8, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 29624 | $27.48 | 1,632,286.0000 | 45,373,033 | 1.78% | 0.07% |
| May 11, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 5890 | $30.56 | 1,613,519.0000 | 45,373,033 | 0.36% | 0.01% |
| May 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 9544 | $28.12 | 1,706,639.0000 | 45,373,033 | 0.56% | 0.02% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 9136 | $27.50 | 1,722,618.0000 | 45,373,033 | 0.53% | 0.02% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 5427 | $28.37 | 1,717,191.0000 | 45,373,033 | 0.32% | 0.01% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 311 | $29.56 | 1,716,880.0000 | 45,373,033 | 0.02% | 0.00% |
| May 4, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 697 | $30.08 | 1,716,183.0000 | 45,373,033 | 0.04% | 0.00% |
| May 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 928 | $29.00 | 1,705,711.0000 | 45,373,033 | 0.05% | 0.00% |
| May 6, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 8098 | $28.04 | 1,697,613.0000 | 45,373,033 | 0.47% | 0.02% |
| May 6, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 15603 | $29.13 | 1,682,010.0000 | 45,373,033 | 0.92% | 0.03% |
| April 16, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 7575 | $27.49 | 1,731,754.0000 | 45,373,033 | 0.44% | 0.02% |
| April 16, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 2477 | $27.01 | 1,739,329.0000 | 45,373,033 | 0.14% | 0.01% |
| April 15, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 9135 | $26.93 | 1,741,806.0000 | 45,373,033 | 0.52% | 0.02% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Employee Stock Option (right to buy) | 93955 | $0.00 | 93,955.0000 | 45,373,033 | 9999.99% | 0.21% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Voting Common Stock | 23145 | $0.00 | 1,750,941.0000 | 45,373,033 | 1.34% | 0.05% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | F | Voting Common Stock | 204146 | $17.98 | 1,727,796.0000 | 45,373,033 | 10.57% | 0.45% |
| Oct. 28, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | C | Voting Common Stock | 3895 | $0.00 | 330,778.0000 | 0 | 1.19% | 0.00% |
| Oct. 28, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | C | Series C Preferred Stock | 65477 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Employee Stock Option (right to buy) | 916164 | $0.00 | 916,164.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kroeger Christopher A. | Chief Executive Officer | A | Voting Common Stock | 225693 | $0.00 | 326,883.0000 | 0 | 223.04% | 0.00% |